Pharming Group N.V (PHAR) Long-Term Debt Repayments: 2020-2023
- Pharming Group N.V's Long-Term Debt Repayments fell 59.19% to $91,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $736,000, marking a year-over-year change of. This contributed to the annual value of -$57,231 for FY2020, which is 99.84% up from last year.
- Latest data reveals that Pharming Group N.V reported Long-Term Debt Repayments of $91,000 as of Q2 2023, which was down 60.09% from $228,000 recorded in Q4 2022.
- Pharming Group N.V's 5-year Long-Term Debt Repayments high stood at $56.2 million for Q4 2020, and its period low was $91,000 during Q2 2023.
- In the last 3 years, Pharming Group N.V's Long-Term Debt Repayments had a median value of $208,500 in 2021 and averaged $184,000.
- As far as peak fluctuations go, Pharming Group N.V's Long-Term Debt Repayments crashed by 99.65% in 2021, and later climbed by 17.53% in 2022.
- Pharming Group N.V's Long-Term Debt Repayments (Quarterly) stood at $56.2 million in 2020, then plummeted by 99.65% to $194,000 in 2021, then climbed by 17.53% to $228,000 in 2022, then slumped by 59.19% to $91,000 in 2023.
- Its Long-Term Debt Repayments stands at $91,000 for Q2 2023, versus $228,000 for Q4 2022 and $223,000 for Q2 2022.
